Literature DB >> 20874522

Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer.

Marco Candela1, Marco Guidotti, Alessia Fabbri, Patrizia Brigidi, Claudio Franceschi, Carla Fiorentini.   

Abstract

In this review, we discuss the multifactorial role of intestinal microbiota in colorectal cancer. The peculiar metabolism of dietary compounds of the individual microbiota complement, its overall immunostimulation and immunomodulatory activity, and eventually the production of toxins that perturb the regulation of cell growth, define the balance of positive and negative risk factors for colorectal cancer development. Moreover, shaping the composition of the human intestinal microbiota, diet has an indirect impact in determining the balance between health and disease. The integration of diet, microbial, and host factors in a system approach is mandatory to determine the overall balance of risk and protective factors for colorectal cancer onset.

Entities:  

Mesh：

Year:  2010        PMID： 20874522     DOI： 10.3109/1040841X.2010.501760

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN： 1040-841X            Impact factor:   7.624


  40 in total

1.  Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colon.

Authors:  Reetta Holma; Pia Osterlund; Ulla Sairanen; Mikko Blom; Merja Rautio; Riitta Korpela
Journal:  Int J Colorectal Dis       Date:  2011-10-18       Impact factor: 2.571

Review 2.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

3.  Significant changes in the intestinal environment after surgery in patients with colorectal cancer.

Authors:  Seiji Ohigashi; Kazuki Sudo; Daiki Kobayashi; Takuya Takahashi; Koji Nomoto; Hisashi Onodera
Journal:  J Gastrointest Surg       Date:  2013-06-27       Impact factor: 3.452

4.  Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response.

Authors:  Riccardo Guidi; Lina Guerra; Laura Levi; Bo Stenerlöw; James G Fox; Christine Josenhans; Maria G Masucci; Teresa Frisan
Journal:  Cell Microbiol       Date:  2012-11-01       Impact factor: 3.715

5.  Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression.

Authors:  Venkatakrishna R Jala; Paramahamsa Maturu; Sobha R Bodduluri; Elangovan Krishnan; Steven Mathis; Krishnaprasad Subbarao; Min Wang; Alfred B Jenson; Mary L Proctor; Eric C Rouchka; Rob Knight; Bodduluri Haribabu
Journal:  Oncoimmunology       Date:  2017-08-10       Impact factor: 8.110

Review 6.  The intestinal microbiota and chronic disorders of the gut.

Authors:  Andrew W DuPont; Herbert L DuPont
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-16       Impact factor: 46.802

Review 7.  Gut microbial metabolites associated with HIV infection.

Authors:  Zheng Wang; Qibin Qi
Journal:  Future Virol       Date:  2019-05-15       Impact factor: 1.831

8.  Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers.

Authors:  L Mira-Pascual; R Cabrera-Rubio; S Ocon; P Costales; A Parra; A Suarez; F Moris; L Rodrigo; A Mira; M C Collado
Journal:  J Gastroenterol       Date:  2014-05-09       Impact factor: 7.527

Review 9.  Inflammation and colorectal cancer, when microbiota-host mutualism breaks.

Authors:  Marco Candela; Silvia Turroni; Elena Biagi; Franck Carbonero; Simone Rampelli; Carla Fiorentini; Patrizia Brigidi
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 10.  The yin and yang of leukotriene B4 mediated inflammation in cancer.

Authors:  Venkatakrishna R Jala; Sobha R Bodduluri; Shuchismita R Satpathy; Zinal Chheda; Rajesh K Sharma; Bodduluri Haribabu
Journal:  Semin Immunol       Date:  2017-10-02       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.